Erectile dysfunction (ED) is quickly becoming more common, but may still be widely under-treated. Research conducted since the 1980's has shown that ED occurs due to physiological and psychological factors instead of one or the other; treatment of ED has evolved in this same time frame.
"The last two decades have seen a dramatic growth of understanding in the physiology of erection, the pathophysiology of ED and its treatment options..." Whereas Cialis, the brand of tadlafil, functions as a phosphodiesterase type 5 (PDE5) inhibitor like other ED therapies such as sildenafil, its duration of efficacy is much longer. Tadalafil has a half-life in human tissue of 17.5 in young, healthy adults.
Tadalafil in the treatment of erectile dysfunction
With the growing need for treatment, more doctors, including general practitioners, are prescribing